Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philip A. Sharp Insider Profile
4 Followers
Philip A. Sharp, Director at Alnylam Pharma, holds 266.90K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Syros Pharmaceuticals (Ticker: SYRS), holds 254.51K shares in Vir Biotechnology (Ticker: VIR).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+167.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Philip A. Sharp holds in companies
Most Profitable Insider Trade
The most profitable trade made by Philip A. Sharp
Philip A. Sharp's Trading History
Alnylam Pharma
Mar 01, 2024
Director
Uninformative Sell
4.54M
$40.65M
Syros Pharmaceuticals
―
Director
―
―
Vir Biotechnology
May 24, 2023
Director
Uninformative Buy
―
$2.43M
Biogen
Jun 05, 2009
Director
Uninformative Buy
―
$103.33M
List of latest transactions for each holding click on a transaction to see Philip A. Sharp's performance on stock
You May Also Like
Philip A. Sharp insider profile FAQ
What is the percentage of profitable transactions made by Philip A. Sharp?
The percentage of profitable transactions made by Philip A. Sharp is 100%.
What is the average return per transaction made by Philip A. Sharp?
The average return per transaction made by Philip A. Sharp is 167.30%.
What stocks does Philip A. Sharp hold?
Philip A. Sharp holds: ALNY, SYRS, VIR, BIIB stocks.
What was Philip A. Sharp’s latest transaction?
Philip A. Sharp latest transaction was an Uninformative Sell of $4.54M.
What was Philip A. Sharp's most profitable transaction?
Philip A. Sharp’s most profitable transaction was an Informative Buy of ALNY stock on January 24, 2013. The return on the trade was 251.10%.
What is Philip A. Sharp's role in Alnylam Pharma?
Philip A. Sharp's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.